Literature DB >> 25156927

Chorea associated with Huntington's disease: to treat or not to treat?

Joseph Jankovic1, Raymund A C Roos.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25156927     DOI： 10.1002/mds.25996

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  13 in total

Review 1.  Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.

Authors:  Young-A Heo; Lesley J Scott
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

Review 2.  Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies.

Authors:  Deepa Dash; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

3.  Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.

Authors:  Carey Wexler Sherman; Ravi Iyer; Victor Abler; Alexandria Antonelli; Noelle E Carlozzi
Journal:  Neuropsychol Rehabil       Date:  2019-03-08       Impact factor: 2.868

4.  Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Authors:  Samuel Frank; David Stamler; Elise Kayson; Daniel O Claassen; Amy Colcher; Charles Davis; Andrew Duker; Shirley Eberly; Lawrence Elmer; Erin Furr-Stimming; Mark Gudesblatt; Christine Hunter; Joseph Jankovic; Sandra K Kostyk; Rajeev Kumar; Clement Loy; William Mallonee; David Oakes; Burton L Scott; Victor Sung; Jody Goldstein; Christina Vaughan; Claudia M Testa
Journal:  JAMA Neurol       Date:  2017-08-01       Impact factor: 18.302

5.  Patient-reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro-QoL) and Huntington's disease health-related quality of life (HDQLIFE) physical function measures.

Authors:  Noelle E Carlozzi; Rebecca E Ready; Samuel Frank; David Cella; Elizabeth A Hahn; Siera M Goodnight; Stephen G Schilling; Nicholas R Boileau; Praveen Dayalu
Journal:  Mov Disord       Date:  2017-05-27       Impact factor: 10.338

6.  deutetrabenazine for the treatment of chorea associated with Huntington's disease.

Authors:  Harshit Gupta; Wil Perkins; Cain Stark; Sathya Kikkeri; Juyeon Kakazu; Adam Kaye; Alan Kaye
Journal:  Health Psychol Res       Date:  2022-06-28

7.  HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).

Authors:  N E Carlozzi; S G Schilling; J-S Lai; J S Paulsen; E A Hahn; J S Perlmutter; C A Ross; N R Downing; A L Kratz; M K McCormack; M A Nance; K A Quaid; J C Stout; R C Gershon; R E Ready; J A Miner; S K Barton; S L Perlman; S M Rao; S Frank; I Shoulson; H Marin; M D Geschwind; P Dayalu; S M Goodnight; D Cella
Journal:  Qual Life Res       Date:  2016-08-13       Impact factor: 4.147

8.  The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea.

Authors:  N E Carlozzi; N R Downing; S G Schilling; J-S Lai; S M Goodnight; J A Miner; S A Frank
Journal:  Qual Life Res       Date:  2016-05-03       Impact factor: 4.147

Review 9.  Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.

Authors:  Javier Fernández-Ruiz; María A Moro; José Martínez-Orgado
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 10.  Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.

Authors:  Emma M Coppen; Raymund A C Roos
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.